Share page on LinkedIn

Infectious Diseases

COVID-19 has raised the importance of research into fighting infectious diseases that threaten populations.

A framework for understanding the antimicrobial crisis

Antimicrobial resistance

The World Health Organization calls antimicrobial resistance, resulting from the overuse of antibiotics or other drugs, one of the top 10 public health threats. In fact, the next global pandemic could be another novel respiratory pathogen of zoonotic origins or a multidrug resistant strain of a previously eradicated pathogen.

In this whitepaper we provide a framework for understanding the antimicrobial crisis and the role healthcare and biopharma industries have to play in mitigating the impact of future pandemics.

Read the whitepaper
The evolution of HIV treatments

The evolution of HIV treatments

HIV is highly heterogeneous, creating barriers to diagnosing and treating the disease. Moreover, the HIV epidemic varies by region and country, necessitating different clinical research strategies across geographies. In this whitepaper, we discuss opportunities for addressing these challenges, best practices for managing infectious disease clinical trials and recent developments in HIV treatment.

Read the whitepaper
Pandemic respiratory vaccine clinical trials: A departure from business as usual

Pandemic respiratory vaccine clinical trials: A departure from business as usual

Vaccine trials for respiratory viruses, even in the best of circumstances, present a number of operational challenges for researchers, many of which are exacerbated in the face of a pandemic created by a novel virus. We focus on the corresponding success factors that can keep pandemic respiratory vaccine trials running at optimal speed and efficiency. 

Read the whitepaper
HIV infographic

HIV infographic

HIV treatments: What has been achieved?

Before antiretroviral treatment availability, life expectancy for a person living with HIV was reduced by approximately 12.5 years. Now, this same individual will have near-normal life expectancy.

Download the infographic

Infectious diseases and vaccines media contributions

Receive more insights on infectious diseases and vaccines from ICON

Please visit ICON's Preference Centre and select 'Infectious Diseases and Vaccines' under 'Therapeutic Areas of Interest' to receive new insights on infectious diseases and vaccines.

Receive new insights

Infectious diseases and vaccines services

ICON’s extensive Infectious Disease expertise enables us to consistently select the best sites, expedite start-up timelines, and achieve enrolment targets for our clients. We apply proven strategies to clinical trials that minimise risk and generate high-quality, reliable data reducing the time and cost of bringing new therapies to market.

Read more about ICON's services in infectious diseases and vaccines